Company Filing History:
Years Active: 2019
Title: Dominik Heckmann: Innovator in Sugammadex Preparation
Introduction
Dominik Heckmann is a notable inventor based in Friedberg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of sugammadex, a drug used in anesthesia.
Latest Patents
Heckmann holds a patent for a process for the preparation of sugammadex and its intermediates. This innovative process involves the halogenation of γ-cyclodextrin in a suitable organic solvent to produce 6-per-deoxy-6-per-halo-γ-cyclodextrin. The halogenated γ-cyclodextrin is then reacted with 3-mercaptopropionic acid in the presence of an alkoxide base to obtain sugammadex. The application also details the isolation of 6-per-deoxy-6-per-chloro-γ-cyclodextrin as a crystalline compound, which is essential for the preparation of sugammadex.
Career Highlights
Heckmann is currently employed at Fresenius Kabi Ipsum S.r.l., where he continues to advance his research and development efforts. His work has been instrumental in improving the efficiency and effectiveness of drug preparation processes.
Collaborations
Heckmann has collaborated with notable colleagues, including Walter Cabri and Antonio Ricci. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Dominik Heckmann's contributions to the field of pharmaceutical chemistry, particularly through his patent on sugammadex preparation, highlight his role as an influential inventor. His ongoing work at Fresenius Kabi Ipsum S.r.l. and collaborations with esteemed colleagues further underscore his commitment to advancing medical science.